Search

everythinglearnresearchcommunity

for

Search:↓

Combining synthetic and herbal treatments may help with hair loss, but more research is needed.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Nanomaterials show promise in improving wound healing but require more research on their potential toxicity.

Venlafaxine can cause hair loss, which stops after discontinuation.

Rice husk and bran extracts from the Bue Bang 3 CMU variety can potentially treat hair loss due to their antioxidant, anti-inflammatory, and anti-androgenic properties.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Cosmetic foam product reduces hair loss and increases hair density in men.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Dermatologists should address erectile dysfunction in patients with skin conditions to improve their quality of life.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Hair loss in men treated best with early medication or transplant, new treatments researched.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Minoxidil might help treat acne scars by reducing collagen buildup.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Laser Doppler velocimetry is a valuable noninvasive tool for skin blood flow research in dermatology.

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.